Data Releases

Addition of drug revocation table

This update adds a new table, 'drug_revocations', that contains records of drug entries that have been revoked from DrugBank.

Addition of 781 new drugs derived from International Nonproprietary Names (INN)

This releases introduces another batch of 781 new experimental drugs into DrugBank, all of which have been granted International Nonproprietary Names (INN).

Addition of references for structured drug indications

This update adds a new referencer_type (StructuredIndication) to citation tables and a new column to the ‘structured_indications’ table ('reference_id'). These features allow each indication to be linked back to the source from which it was identified.

Addition of disease/non-disease filtering on conditions

This update adds two additional fields to the ‘conditions’ table. The ‘is_disease’ field is a Boolean flag that indicates whether or not a given condition is a human disease, and ‘is_disease_source' provides a source for the classification (e.g. manual curation).

Enhanced mapping of conditions to other vocabularies

This update enhances the mapping between DrugBank’s conditions data and external biomedical ontologies (e.g. MedDRA) by mapping multiple identifiers per vocabulary, where appropriate. This change should facilitate more complete mapping to, and integration with, other biomedical ontologies.

For CSV data, a new table ('condition_external_identifiers') has been added. For JSON and XML data, a new field has been added to conditions which contains an array of all available identifiers.

Expanded RxCUI coverage

This update adds new product-level (SBD, SCD) and package-level (BPCK, GPCK) term types, and enhances coverage of existing RxCUI term types. It adds ~25,000 additional mappings between RxCUIs and DrugBank product concepts.

Addition of condition hierarchy

This release adds a new table, condition_children, that establishes parent-child relationships between conditions in the conditions table.

Addition of 500 new drugs derived from International Nonproprietary Names (INN)

This releases introduces another batch of 500 new experimental drugs into DrugBank, all of which have been granted International Nonproprietary Names (INN).

Addition of 500 new drugs derived from International Nonproprietary Names (INN)

This release introduces 500 new experimental drugs into DrugBank, all of which have been granted International Nonproprietary Names (INN).